DKSC (Dakshidin) Other Current Receivables: $0.00 Mil (As of Sep. 2023)


What is Dakshidin Other Current Receivables?

Dakshidin DKSC +33.33% Other Current Receivables is $0.00 Mil as of Sep. 2023.

Dakshidin's Other Current Receivables for the quarter that ended in Sep. 2023 was $0.00 Mil.

Dakshidin Other Current Receivables Related Terms

Dakshidin Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Dakshidin's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dakshidin Other Current Receivables Chart

Dakshidin Annual Data
Trend
Other Current Receivables

Dakshidin Quarterly Data
Mar19 Mar20 Sep22 Sep23
Other Current Receivables 0.00 0.00 0.00 0.00

Dakshidin Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $0.00 Mil mean?
Dakshidin (DKSC) has a Other Current Receivables of $0.00 Mil as of Sep. 2023. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Dakshidin and its competitors.
Is Dakshidin's Other Current Receivables too high?
Dakshidin's current Other Current Receivables is $0.00 Mil.
How does Dakshidin's Other Current Receivables compare to ECEZ and AFBG?
Dakshidin's Other Current Receivables of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Drug Manufacturers company?
A good Other Current Receivables depends on the Drug Manufacturers industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Dakshidin and its competitors. Dakshidin's current Other Current Receivables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dakshidin stock overvalued right now?
Dakshidin (DKSC) has a current Other Current Receivables of $0.00 Mil. The current Other Current Receivables is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Dakshidin (DKSC), the current Other Current Receivables is $0.00 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dakshidin Business Description

Address 508 Locust Street, Lockport, NY, USA, 14094
Dakshidin Corp is a Cannabis-based medical product company. The company operates through its online e-commerce store laughingfrogs.com. The company is composed of four synergistic entities: Laughing Frogs, an online sales portal for the company's CBD products; Laughing Frogs Nutraceutical the online sales portal for all non-CBD hemp oil products and its proprietary nutraceutical products, company's new PPE division and Runnymede Farms, a company that is focused on the cultivation of specifically grown Hemp plants. through its growing operations and Joint Ventures with established growers.